This is supported by renal disease; patients with proteinuria have higher levels of CD36 expression in the renal proximal convoluted tubule, while treatment of mice with induced chronic kidney disease with the CD36 inhibitor 5A peptide reduces interstitial fibrosis (Souza et al., 2016). Here, CD36 is linked to chronic kidney disease.